Professor Patrick Gunning, a medicinal chemist whose lab at the University of Toronto is revolutionizing how cancer-killing drugs are produced, has signed a $22-million investment deal for Janpix, an oncology-focused startup that he co-founded. The investment came from Medicxi, a European venture capital firm.
